comparemela.com

Page 11 - Ying Huang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Federal COVID relief props up CPS proposed budget

ASCO Recap: Multiple Myeloma Moves, ADC Advances & Brain Cancer Progress

During the annual meeting of the American Society of Clinical Oncology, a cell therapy posted clinical data during that could broaden its use in multiple myeloma. In other developments, the class of drugs called ADCs continue to make progress and a novel brain cancer drug has Phase 3 data that support its use as a new treatment option.

Legend Biotech Announces Submission of Supplemental Application to the U S FDA for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.